Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9589182 | 0.99 | AGTR1 (0.74) | AGTR1AGTR2 | |
| Hydrochloric Acid SCHEMBL9589709 | 0.94 | AGTR1 (0.72) | AGTR1AGTR2 | |
| SCHEMBL9590097 | 0.90 | AGTR1 (0.60) | AGTR1AGTR2 | |
| SCHEMBL9589609 | 0.88 | AGTR1 (0.73) | AGTR1AGTR2 | |
| SCHEMBL9590480 | 0.88 | AGTR1 (0.59) | AGTR1AGTR2 | |
| SCHEMBL9591236 | 0.87 | AGTR1 (0.58) | AGTR1AGTR2 | |
| SCHEMBL9591954 | 0.87 | AGTR1 (0.58) | AGTR1AGTR2 | |
| SCHEMBL9599497 | 0.87 | AGTR1 (0.74) | AGTR1AGTR2 | |
| Hydrochloric Acid SCHEMBL9591762 | 0.87 | AGTR1 (0.74) | AGTR1AGTR2 | |
| Methylamine SCHEMBL9590818 | 0.86 | AGTR1 (0.71) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0475206-A2 | Angiotensin II receptor antagonists | ABBOTT LABORATORIES (US) | 1992-03-18 | — | — | EP | claimed |
| US-6218414-B1 | ADMINISTERING AN EFFECTIVE AMOUNT OF AN ANGIOTENSIN II ANTAGONIST AND A BENZOFURAN DERIVATIVE WITH ANTIARRHYTHMIC ACTIVITY FOR THERAPY OF CARDIOVASCULAR COMPLAINTS | SANOFI (FR) | 2001-04-17 | — | — | US | disclosed |
| US-5250548-A | Treating hypertension, heart failure | ABBOTT LABORATORIES (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0475206-A2 | Angiotensin II receptor antagonists | ABBOTT LABORATORIES (US) | 1992-03-18 | — | — | EP | disclosed |